MOORE ALISON
Insider CIK 1754937 · CDXS President and CEO, Director · ALLO Chief Technical Officer · ARTV Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CDXS CODEXIS, INC. | S Sale | 2026-10-12 | 2026-10-14 | 6,335 | $1.36 | $8.6K | 244,171 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2026-09-10 | 2026-09-14 | 16,250 | — | $0 | 16,250 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2026-09-10 | 2026-09-14 | 16,250 | — | $0 | 16,250 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2026-09-08 | 2026-09-08 | 13,750 | — | $0 | 13,750 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2026-09-08 | 2026-09-08 | 13,750 | — | $0 | 13,750 | SEC↗ |
| CDXS CODEXIS, INC. | A Award deriv | 2026-02-23 | 2026-02-25 | 993,000 | — | $0 | 993,000 | SEC↗ |
| CDXS CODEXIS, INC. | S Sale | 2026-02-06 | 2026-02-09 | 3,826 | $1.31 | $5.0K | 250,506 | SEC↗ |
| CDXS CODEXIS, INC. | A Award deriv | 2025-11-13 | 2025-11-17 | 500,000 | — | $0 | 500,000 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2025-11-13 | 2025-11-17 | 85,000 | — | $0 | 254,332 | SEC↗ |
| CDXS CODEXIS, INC. | S Sale | 2025-10-13 | 2025-10-15 | 6,239 | $2.51 | $15.7K | 169,332 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2025-06-24 | 2025-06-26 | 13,750 | — | $0 | 13,750 | SEC↗ |
| CDXS CODEXIS, INC. | A Award deriv | 2025-02-05 | 2025-02-07 | 161,250 | — | $0 | 161,250 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2025-02-05 | 2025-02-07 | 26,875 | — | $0 | 175,571 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2024-10-21 | 2024-10-22 | 27,500 | — | $0 | 27,500 | SEC↗ |
| CDXS CODEXIS, INC. | A Award deriv | 2024-10-10 | 2024-10-10 | 300,000 | — | $0 | 300,000 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2024-10-10 | 2024-10-10 | 50,000 | — | $0 | 148,696 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2024-06-11 | 2024-06-13 | 30,120 | — | $0 | 98,696 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2023-06-13 | 2023-06-15 | 34,602 | — | $0 | 68,576 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2023-03-22 | 2023-03-24 | 432,738 | — | $0 | 432,738 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2023-03-22 | 2023-03-24 | 558,094 | — | $0 | 672,731 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | F Tax w/h | 2023-03-14 | 2023-03-16 | 8,351 | $5.51 | $46.0K | 114,637 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2022-06-14 | 2022-06-16 | 11,273 | — | $0 | 33,974 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2022-03-23 | 2022-03-25 | 737,179 | — | $0 | 737,179 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2022-03-15 | 2022-03-17 | 8,698 | $7.63 | $66.4K | 120,430 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2021-06-15 | 2021-06-17 | 4,796 | — | $0 | 22,701 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2021-03-26 | 2021-03-30 | 92,365 | — | $0 | 92,365 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2021-03-26 | 2021-03-30 | 24,866 | — | $0 | 127,440 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2021-03-15 | 2021-03-17 | 6,164 | $38.14 | $235.1K | 102,574 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise deriv | 2020-10-13 | 2020-10-13 | 11,031 | — | $0 | 579,959 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2020-10-13 | 2020-10-13 | 11,031 | $42.00 | $463.3K | 108,370 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise | 2020-10-13 | 2020-10-13 | 11,031 | $2.27 | $25.0K | 119,401 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise deriv | 2020-10-12 | 2020-10-13 | 24,233 | — | $0 | 590,990 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise | 2020-10-12 | 2020-10-13 | 24,233 | $2.27 | $55.0K | 132,603 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2020-10-12 | 2020-10-13 | 24,233 | $42.00 | $1.02M | 108,370 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise deriv | 2020-10-09 | 2020-10-09 | 30,199 | — | $0 | 615,223 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2020-10-09 | 2020-10-09 | 39,509 | $41.00 | $1.62M | 108,370 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise | 2020-10-09 | 2020-10-09 | 30,199 | $2.27 | $68.6K | 147,879 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise deriv | 2020-10-08 | 2020-10-09 | 5,065 | — | $0 | 645,422 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise | 2020-10-08 | 2020-10-09 | 5,065 | $2.27 | $11.5K | 122,745 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2020-10-08 | 2020-10-09 | 5,065 | $41.00 | $207.7K | 117,680 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise deriv | 2020-10-06 | 2020-10-08 | 35,264 | — | $0 | 650,487 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise | 2020-10-06 | 2020-10-08 | 35,264 | $2.27 | $80.0K | 161,536 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2020-10-06 | 2020-10-08 | 44,574 | $40.00 | $1.78M | 117,680 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise deriv | 2020-08-13 | 2020-08-14 | 32,451 | — | $0 | 685,751 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise | 2020-08-13 | 2020-08-14 | 32,451 | $2.27 | $73.7K | 126,272 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2020-06-16 | 2020-06-18 | 17,905 | — | $0 | 17,905 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2020-03-18 | 2020-03-20 | 109,600 | — | $0 | 109,600 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2020-03-18 | 2020-03-20 | 30,800 | — | $0 | 93,821 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2020-03-16 | 2020-03-18 | 3,750 | $19.19 | $72.0K | 63,021 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise deriv | 2019-09-18 | 2019-09-18 | 21,067 | — | $0 | 718,202 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise | 2019-09-18 | 2019-09-18 | 21,067 | $2.27 | $47.8K | 87,134 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2019-09-18 | 2019-09-18 | 21,067 | $32.13 | $676.9K | 66,067 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise deriv | 2019-09-17 | 2019-09-18 | 22,503 | — | $0 | 739,269 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise | 2019-09-17 | 2019-09-18 | 22,503 | $2.27 | $51.1K | 88,570 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2019-09-17 | 2019-09-18 | 22,503 | $32.11 | $722.6K | 66,067 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise deriv | 2019-09-16 | 2019-09-18 | 5,257 | — | $0 | 761,772 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2019-09-16 | 2019-09-18 | 5,257 | $32.00 | $168.2K | 66,067 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise | 2019-09-16 | 2019-09-18 | 5,257 | $2.27 | $11.9K | 71,324 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise deriv | 2019-07-30 | 2019-07-30 | 11,819 | — | $0 | 767,029 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2019-07-30 | 2019-07-30 | 11,819 | $29.85 | $352.8K | 65,373 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise | 2019-07-30 | 2019-07-30 | 11,819 | $2.27 | $26.8K | 77,192 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise deriv | 2019-07-29 | 2019-07-30 | 23,815 | — | $0 | 778,848 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2019-07-29 | 2019-07-30 | 23,815 | $29.39 | $699.9K | 65,373 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise | 2019-07-29 | 2019-07-30 | 23,815 | $2.27 | $54.1K | 89,188 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise deriv | 2019-07-26 | 2019-07-30 | 13,193 | — | $0 | 802,663 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2019-07-26 | 2019-07-30 | 13,193 | $29.18 | $385.0K | 65,373 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise | 2019-07-26 | 2019-07-30 | 13,193 | $2.27 | $29.9K | 78,566 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise deriv | 2019-06-28 | 2019-07-01 | 27,816 | — | $0 | 815,856 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise | 2019-06-28 | 2019-07-01 | 27,816 | $2.27 | $63.1K | 65,373 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise deriv | 2019-06-03 | 2019-06-05 | 48,828 | — | $0 | 843,672 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise | 2019-06-03 | 2019-06-05 | 48,828 | $2.27 | $110.8K | 86,385 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2019-06-03 | 2019-06-05 | 47,205 | $26.74 | $1.26M | 39,180 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2019-06-03 | 2019-06-05 | 1,623 | $27.31 | $44.3K | 37,557 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2019-03-13 | 2019-03-15 | 83,500 | — | $0 | 83,500 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2019-03-13 | 2019-03-15 | 37,050 | — | $0 | 37,050 | SEC↗ |